Ciphergen receives Nasdaq non-compliance notice

AnaCampoy

SAN FRANCISCO (MarketWatch) -- Ciphergen Biosystems Inc.
CIP.H, -28.57%
after Friday's closing bell said it was notified by Nasdaq that the company has failed to comply with the continued listing requirements because its market value has fallen below $50 million for 10 consecutive business days. On June 26 the company received a Nasdaq staff determination letter indicating its securities are subject to delisting. The Fremont, Calif.-based diagnostic tests company plans to request a hearing before a Nasdaq panel to appeal the staff determination.

Intraday Data provided by SIX Financial Information and subject to terms of use.
Historical and current end-of-day data provided by SIX Financial Information. Intraday data
delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Dow Jones & Company, Inc.
All quotes are in local exchange time. Real time last sale data provided by NASDAQ. More
information on NASDAQ traded symbols and their current financial status. Intraday
data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. S&P/Dow Jones Indices (SM)
from Dow Jones & Company, Inc. SEHK intraday data is provided by SIX Financial Information and is
at least 60-minutes delayed. All quotes are in local exchange time.